Skip to main content

01.09.2012 | Original Article

Validation of a screening tool for identifying Brazilians with impaired glucose tolerance

verfasst von: Bruno Pereira de Moura, Paulo Roberto do Santos Amorim, Sylvia do Carmo Castro Franceschini, Janice Sepúlveda Reis, João Carlos Bouzas Marins

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to validate a self-assessment tool for identifying Brazilians with Impaired Glucose Tolerance (IGT). The Finnish Diabetes Risk Score (FINDRISC) was applied in 829 people aged over 40 years without previous diagnosis of diabetes between November 2009 and April 2010 at the Viçosa city, Minas Gerais, Brazil. We randomly selected 300 subjects in the initial survey, which received by post a letter of invitation to attend the laboratory for the collection of the blood sample to identify levels of glycated hemoglobin (A1C). Of these 300 subjects invited, 162 attended subjects, this being the final sample for the validation study. The risk score was evaluated through the Area Under the Curve (AUC) in a Receiver Operating Characteristics (ROC) curve. We assume a maximum error of 5 % and confidence interval 95 %. The prevalence of IGT and diabetes according to the A1C test were 21.6 % and 8.6 % respectively. The Diabetes Risk Score value varied from 1 to 25. The AUC by considering all values of A1C ≥ 6.0 % was 0.69 (95 % CI 0.61–0.76). The score value ≥ 9 had sensitivity of 75.51 %, specificity of 49.56 %, Positive Predictive Value (PPV) of 39.4 % and Negative Predictive Value (NPV) of 82.4 %. The FINDRISC is a suitable tool to identify Brazilians with IGT.
Literatur
5.
Zurück zum Zitat Schwarz PE, Li J, Reimann M, Schutte AE, Bergmann A, Hanefeld M, Bornstein SR, Schulze J, Tuomilehto J, Lindstrom J. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab. 2009;94:920–6.PubMedCrossRef Schwarz PE, Li J, Reimann M, Schutte AE, Bergmann A, Hanefeld M, Bornstein SR, Schulze J, Tuomilehto J, Lindstrom J. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab. 2009;94:920–6.PubMedCrossRef
6.
Zurück zum Zitat Screening for type 2 diabetes. Diabetes Care. 2004;27 Suppl 1:S11–4. Screening for type 2 diabetes. Diabetes Care. 2004;27 Suppl 1:S11–4.
7.
Zurück zum Zitat Standards of medical care in diabetes—2010. Diabetes Care. 2010; 33 Suppl 1:S11–61. Standards of medical care in diabetes—2010. Diabetes Care. 2010; 33 Suppl 1:S11–61.
8.
Zurück zum Zitat Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res. 2008;41:86–97.PubMedCrossRef Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res. 2008;41:86–97.PubMedCrossRef
9.
Zurück zum Zitat Gao WG, Qiao Q, Pitkaniemi J, Wild S, Magliano D, Shaw J, Soderberg S, Zimmet P, Chitson P, Knowlessur S, et al. Risk prediction models for the development of diabetes in Mauritian Indians. Diabet Med. 2009;26:996–1002.PubMedCrossRef Gao WG, Qiao Q, Pitkaniemi J, Wild S, Magliano D, Shaw J, Soderberg S, Zimmet P, Chitson P, Knowlessur S, et al. Risk prediction models for the development of diabetes in Mauritian Indians. Diabet Med. 2009;26:996–1002.PubMedCrossRef
10.
Zurück zum Zitat Gao WG, Dong YH, Pang ZC, Nan HR, Wang SJ, Ren J, Zhang L, Tuomilehto J, Qiao Q. A simple Chinese risk score for undiagnosed diabetes. Diabet Med. 2010;27:274–81.PubMedCrossRef Gao WG, Dong YH, Pang ZC, Nan HR, Wang SJ, Ren J, Zhang L, Tuomilehto J, Qiao Q. A simple Chinese risk score for undiagnosed diabetes. Diabet Med. 2010;27:274–81.PubMedCrossRef
11.
Zurück zum Zitat Cabrera de Leon A, Coello SD, Rodriguez Perez Mdel C, Medina MB, Almeida Gonzalez D, Diaz BB, de Fuentes MM, Aguirre-Jaime A. A simple clinical score for type 2 diabetes mellitus screening in the Canary Islands. Diabetes Res Clin Pract. 2008;80:128–33.PubMedCrossRef Cabrera de Leon A, Coello SD, Rodriguez Perez Mdel C, Medina MB, Almeida Gonzalez D, Diaz BB, de Fuentes MM, Aguirre-Jaime A. A simple clinical score for type 2 diabetes mellitus screening in the Canary Islands. Diabetes Res Clin Pract. 2008;80:128–33.PubMedCrossRef
12.
Zurück zum Zitat Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care. 2006;29:410–4.PubMedCrossRef Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care. 2006;29:410–4.PubMedCrossRef
13.
Zurück zum Zitat Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26:725–31.PubMedCrossRef Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26:725–31.PubMedCrossRef
15.
Zurück zum Zitat Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva: World Health Organization; 1991. Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva: World Health Organization; 1991.
16.
Zurück zum Zitat International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34.
17.
Zurück zum Zitat Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KM, Imperatore G, Williams DE, Albright AL. A1C level and future risk of diabetes: a systematic review. Diabetes Care. 2010;33:1665–73.PubMedCrossRef Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KM, Imperatore G, Williams DE, Albright AL. A1C level and future risk of diabetes: a systematic review. Diabetes Care. 2010;33:1665–73.PubMedCrossRef
18.
Zurück zum Zitat Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005;2:67–72.PubMedCrossRef Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005;2:67–72.PubMedCrossRef
19.
Zurück zum Zitat Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J. The European perspective of type 2 diabetes prevention: diabetes in Europe–prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes. 2008;116:167–72.PubMedCrossRef Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J. The European perspective of type 2 diabetes prevention: diabetes in Europe–prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes. 2008;116:167–72.PubMedCrossRef
20.
Zurück zum Zitat Schwarz PE, Gruhl U, Bornstein SR, Landgraf R, Hall M, Tuomilehto J. The European perspective on diabetes prevention: development and Implementation of A European Guideline and training standards for diabetes prevention (IMAGE). Diab Vasc Dis Res. 2007;4:353–7.PubMedCrossRef Schwarz PE, Gruhl U, Bornstein SR, Landgraf R, Hall M, Tuomilehto J. The European perspective on diabetes prevention: development and Implementation of A European Guideline and training standards for diabetes prevention (IMAGE). Diab Vasc Dis Res. 2007;4:353–7.PubMedCrossRef
21.
Zurück zum Zitat Tuomilehto J, Lindstrom J, Hellmich M, Lehmacher W, Westermeier T, Evers T, Bruckner A, Peltonen M, Qiao Q, Chiasson JL. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score. Diabetes Res Clin Pract. 2010;87:267–74.PubMedCrossRef Tuomilehto J, Lindstrom J, Hellmich M, Lehmacher W, Westermeier T, Evers T, Bruckner A, Peltonen M, Qiao Q, Chiasson JL. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score. Diabetes Res Clin Pract. 2010;87:267–74.PubMedCrossRef
22.
Zurück zum Zitat Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–9.PubMedCrossRef Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–9.PubMedCrossRef
23.
Zurück zum Zitat Lindstrom J, Peltonen M, Eriksson JG, Aunola S, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Uusitupa M, Tuomilehto J. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care. 2008;31:857–62.PubMedCrossRef Lindstrom J, Peltonen M, Eriksson JG, Aunola S, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Uusitupa M, Tuomilehto J. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care. 2008;31:857–62.PubMedCrossRef
24.
Zurück zum Zitat Goldenberg P, Schenkman S, Franco LJ. Prevalence of diabetes mellitus: gender differences and sex equalities. Rev Bras Epidemiol. 2003;6:18–28.CrossRef Goldenberg P, Schenkman S, Franco LJ. Prevalence of diabetes mellitus: gender differences and sex equalities. Rev Bras Epidemiol. 2003;6:18–28.CrossRef
25.
Zurück zum Zitat Escobedo J, Buitron LV, Velasco MF, Ramirez JC, Hernandez R, Macchia A, Pellegrini F, Schargrodsky H, Boissonnet C, Champagne BM. High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study. Diabet Med. 2009;26:864–71.PubMedCrossRef Escobedo J, Buitron LV, Velasco MF, Ramirez JC, Hernandez R, Macchia A, Pellegrini F, Schargrodsky H, Boissonnet C, Champagne BM. High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study. Diabet Med. 2009;26:864–71.PubMedCrossRef
Metadaten
Titel
Validation of a screening tool for identifying Brazilians with impaired glucose tolerance
verfasst von
Bruno Pereira de Moura
Paulo Roberto do Santos Amorim
Sylvia do Carmo Castro Franceschini
Janice Sepúlveda Reis
João Carlos Bouzas Marins
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 3/2012
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-012-0074-2